Login / Signup

Fibrotic Burden Determines Cardiovascular Risk among Subjects with Metabolic Dysfunction-Associated Fatty Liver Disease.

Eugene HanEun Young LeeJae Seung LeeHye-Won LeeBeom Kyung KimJun Yong ParkDo Young KimSang Hoon AhnByung-Wan LeeEun Seok KangBong Soo ChaSeung-Up Kim
Published in: Gut and liver (2022)
Individuals with MAFLD had a substantial ASCVD risk compared to those without MAFLD. Accompanying significant liver fibrosis further enhanced the risk of ASCVD among subjects with MAFLD.
Keyphrases
  • liver fibrosis
  • oxidative stress
  • systemic sclerosis
  • idiopathic pulmonary fibrosis
  • fatty acid